phenobarbital and glucagon-like peptide 1

phenobarbital has been researched along with glucagon-like peptide 1 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fölsch, UR; Gallwitz, B; Klöppel, G; Reinecke-Lüthge, A; Schmidt, WE; Schmitz, F; Seidenstücker, A; Siegel, EG1
Hara, H; Hira, T; Muramatsu, M; Okuno, M1
Cao, F; Chen, X; Kim, TH; Ma, N; Niu, G; Sun, Z; Tong, G1

Other Studies

3 other study(ies) available for phenobarbital and glucagon-like peptide 1

ArticleYear
Insulin secretion defects in liver cirrhosis can be reversed by glucagon-like peptide-1.
    The Journal of endocrinology, 2000, Volume: 164, Issue:1

    Topics: Analysis of Variance; Animals; Carbon Tetrachloride; Culture Techniques; Dose-Response Relationship, Drug; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Insulin; Insulin Secretion; Islets of Langerhans; Liver Cirrhosis, Experimental; Liver Function Tests; Male; Peptide Fragments; Phenobarbital; Protein Precursors; Rats; Rats, Inbred Lew

2000
GLP-1 secretion in response to oral and luminal palatinose (isomaltulose) in rats.
    Journal of nutritional science and vitaminology, 2011, Volume: 57, Issue:1

    Topics: Administration, Oral; Animals; Cell Line; Enteroendocrine Cells; Glucagon-Like Peptide 1; Glucose; Ileum; Isomaltose; Jejunum; Male; Phenobarbital; Rats; Rats, Sprague-Dawley; Sucrose; Sweetening Agents

2011
PEGylated exendin-4, a modified GLP-1 analog exhibits more potent cardioprotection than its unmodified parent molecule on a dose to dose basis in a murine model of myocardial infarction.
    Theranostics, 2015, Volume: 5, Issue:3

    Topics: Aminophylline; Animals; Atropine; Blotting, Western; Cardiovascular Agents; Disease Models, Animal; Drug Combinations; Exenatide; Glucagon-Like Peptide 1; Heart; Heart Function Tests; Histocytochemistry; Male; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Nitroglycerin; Papaverine; Peptides; Phenobarbital; Survival Analysis; Treatment Outcome; Venoms

2015